JPS55124763U - - Google Patents
Info
- Publication number
- JPS55124763U JPS55124763U JP2640579U JP2640579U JPS55124763U JP S55124763 U JPS55124763 U JP S55124763U JP 2640579 U JP2640579 U JP 2640579U JP 2640579 U JP2640579 U JP 2640579U JP S55124763 U JPS55124763 U JP S55124763U
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2640579U JPS55124763U (enrdf_load_stackoverflow) | 1979-02-28 | 1979-02-28 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2640579U JPS55124763U (enrdf_load_stackoverflow) | 1979-02-28 | 1979-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS55124763U true JPS55124763U (enrdf_load_stackoverflow) | 1980-09-04 |
Family
ID=28868593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2640579U Pending JPS55124763U (enrdf_load_stackoverflow) | 1979-02-28 | 1979-02-28 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS55124763U (enrdf_load_stackoverflow) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7235576B1 (en) | 2001-01-12 | 2007-06-26 | Bayer Pharmaceuticals Corporation | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| US7371763B2 (en) | 2001-04-20 | 2008-05-13 | Bayer Pharmaceuticals Corporation | Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
| US7517880B2 (en) | 1997-12-22 | 2009-04-14 | Bayer Pharmaceuticals Corporation | Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| US7528255B2 (en) | 1999-01-13 | 2009-05-05 | Bayer Pharmaceuticals Corporation | Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors |
| US7625915B2 (en) | 1997-12-22 | 2009-12-01 | Bayer Healthcare Llc | Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas |
| US9181188B2 (en) | 2002-02-11 | 2015-11-10 | Bayer Healthcare Llc | Aryl ureas as kinase inhibitors |
-
1979
- 1979-02-28 JP JP2640579U patent/JPS55124763U/ja active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7517880B2 (en) | 1997-12-22 | 2009-04-14 | Bayer Pharmaceuticals Corporation | Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| US7625915B2 (en) | 1997-12-22 | 2009-12-01 | Bayer Healthcare Llc | Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas |
| US7528255B2 (en) | 1999-01-13 | 2009-05-05 | Bayer Pharmaceuticals Corporation | Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors |
| US7235576B1 (en) | 2001-01-12 | 2007-06-26 | Bayer Pharmaceuticals Corporation | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| US7371763B2 (en) | 2001-04-20 | 2008-05-13 | Bayer Pharmaceuticals Corporation | Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
| US9181188B2 (en) | 2002-02-11 | 2015-11-10 | Bayer Healthcare Llc | Aryl ureas as kinase inhibitors |